Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
Clinical trial NCT02175758 · COMPLETED
Trial details
- NCT number
- NCT02175758
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-07
- Primary completion
- 2018-06-21
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.